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P

roteins belonging to the bacterial tyrosine kinase (BY-kinase)
family have no eukaryotic homologues and were first described as being involved in the biosynthesis of polysaccharides in
several bacterial systems. BY-kinases contain Walker A and
Walker B ATP-binding motifs that bind ATP and use it to promote tyrosine phosphorylation. This posttranslational modification can be reversed by the action of protein tyrosine phosphatases
(PTPs), whose genes are usually located near the genes encoding
BY-kinases. Cycles of tyrosine phosphorylation and dephosphorylation by the actions of BY-kinases and PTP proteins, respectively, have been shown to control the amount of and/or molecular weight of the polysaccharide (1, 2). In addition, several studies
have shown that BY-kinases are able to interact with other proteins that are not connected to polysaccharide biosynthesis, promoting their phosphorylation and thereby controlling their activity and, in some cases, their cellular location (1, 3). Therefore,
BY-kinases are implicated in several cell functions, such as DNA
metabolism, resistance to stress, and cellular division, among others (4–7). Regarding bacterial tyrosine phosphatases, they can be
grouped in the families of the eukaryotic-like phosphatases
(PTPs) and dual-specific phosphatases, the low-molecular-weight
protein tyrosine phosphatases (LMW-PTPs), and the polymerasehistidinol phosphatases (PHPs) (8). Despite many of them being
involved in polysaccharide production (2), several have been implicated in host-bacteria interactions (8). Examples include the
following: the YopH protein tyrosine phosphatase of Yersinia
pseudotuberculosis, which promotes cytoskeletal rearrangements
and inhibition of phagocytosis (9); SptP from Salmonella enterica
serovar Typhimurium and StpA from Salmonella enterica serovar
Typhi, which disrupt the host cell cytoskeleton (10, 11); MptpA
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and MptpB from Mycobacterium tuberculosis, which inhibit
phagosome maturation (12, 13) and subvert the host immune
response (14); LipA of Listeria monocytogenes, which interferes
with the actin cytoskeleton (15); and the nonfunctional tyrosine
phosphatase Dpm of Burkholderia cenocepacia, which has been
implicated in the delayed maturation of bacteria-containing vacuoles in macrophages (16). All these characterized tyrosine phosphatases, acting as effector proteins, are secreted into eukaryotic
cells and, except for MptpA and Dpm, which are LMW-PTPs, all
of the other mentioned enzymes are members of the PTP family
(8, 16).
Bacteria belonging to the Burkholderia cepacia complex are
ubiquitously found in natural environments but also occur as
contaminants in man-made products, such as pharmaceuticals,
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Bacterial tyrosine kinases and their cognate protein tyrosine phosphatases are best known for regulating the biosynthesis of
polysaccharides. Moreover, their roles in the stress response, DNA metabolism, cell division, and virulence have also been documented. The aim of this study was to investigate the pathogenicity and potential mechanisms of virulence dependent on the tyrosine kinase BceF and phosphotyrosine phosphatase BceD of the cystic fibrosis opportunistic pathogen Burkholderia contaminans IST408. The insertion mutants bceD::Tp and bceF::Tp showed similar attenuation of adhesion and invasion of the cystic
fibrosis lung epithelial cell line CFBE41o- compared to the parental strain B. contaminans IST408. In the absence of bceD or bceF
genes, B. contaminans also showed a reduction in the ability to translocate across polarized epithelial cell monolayers, demonstrated by a higher transepithelial electrical resistance, reduced flux of fluorescein isothiocyanate-labeled bovine serum albumin,
and higher levels of tight junction proteins ZO-1, occludin, and claudin-1 present in monolayers exposed to these bacterial mutants. Furthermore, bceD::Tp and bceF::Tp mutants induced lower levels of interleukin-6 (IL-6) and IL-8 release than the parental strain. In conclusion, although the mechanisms of pathogenicity dependent on BceD and BceF are not understood, these proteins contribute to the virulence of Burkholderia by enhancement of cell attachment and invasion, disruption of epithelial
integrity, and modulation of the proinflammatory response.

Roles of BceD and BceF in Bacterium-Host Interactions

MATERIALS AND METHODS
Bacterial strains and media. The bacterial strains used in this study were
the highly mucoid genetically modifiable CF clinical isolate Burkholderia
contaminans IST408 and its derivative insertion mutants bceD::Tp, bceE::
Tp, and bceF::Tp (7, 35) and Escherichia coli strains NCIB9415 (NCIMB,
United Kingdom) and DH5␣ (38). By using recA-based genomovar-specific primer pairs for gene amplification followed by restriction fragment
length polymorphism analysis with HaeIII, strain IST408 was considered
for several years to belong to the species B. cepacia (genomovar I, taxon K).
Recently, with the introduction of the multilocus sequence typing
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(MLST) method (and sequencing of the genes atpD, gltB, gyrB, recA, lepA,
phaC, and trpP), this strain was relocated to the species B. contaminans
(according to the Burkholderia MLST database, it is ST96). This strain has
been used as a model for cepacian biosynthesis (34). All strains were
routinely cultured in Lennox broth (LB) at 37°C. Growth medium was
supplemented with antibiotics when required to maintain the selective
pressure at the following concentrations: for B. contaminans strains, trimethoprim at 100 g/ml and chloramphenicol at 100 g/ml; for E. coli
strains, chloramphenicol at 25 g/ml and kanamycin at 50 g/ml.
DNA manipulation techniques. Genomic DNA was extracted from B.
contaminans IST408 by using the DNeasy blood and tissue kit (Qiagen),
following the manufacturer’s instructions. Plasmid DNA isolation and
purification, DNA restriction, agarose gel electrophoresis, and E. coli
transformation were carried out using standard procedures (39). B. contaminans electrocompetent cells were transformed by electroporation using a Bio-Rad Gene Pulser II system (200 ⍀, 25 F, 2.5 kV) and grown
overnight before being plated on selective medium. Triparental conjugation to B. contaminans strains was performed using the helper plasmid
pRK2013 (40).
Plasmid construction and complementation experiments. Complementation of B. contaminans mutant strains was performed by expressing
bceD, bceE, or bceF from the promoter of the bce operon directing the
biosynthesis of cepacian (41) present in the replicative vector pBBR1MCS
(42). To prepare the plasmids expressing each of the genes, the bce promoter and each gene region were amplified by PCR using B. contaminans
IST408 genomic DNA as the template. The primers used to amplify the bce
promoter region were Pbce-Fw (GATAAGCTTCTCCTCGATTGAAGT
[restriction sites are shown in italics]) and Pbce-Rev (GTGCATATGCTT
CGATTCAAACGT). The primers used to amplify the bceD, bceE, and
bceF genes were bceD-Fw (GCTCATATGCGGAACATCCTGATCGT
CT), bceD-Rev (CACTCTAGAACAGGCTGACAGGAAAGTCG), bceE-Fw
(GAACATATGCTGAAACGCCCGATG), bceE-Rev (TGATCTAGAGGA
GCAGCTGGCCGAGGA), bceF-Fw (GAACATATGGTGAACACGCAA
GCGAAA), and bceF-Rev (TTATCTAGAATGCGGATCAGGCGCTCA).
The amplified promoter region was restricted with HindIII/NdeI, and the
gene regions were restricted with NdeI/XbaI and ligated to the HindIII/
XbaI sites of the intermediate pUK21 vector. Each fragment containing
the bce promoter and one of the gene regions was then cloned into the
pBBR1MCS vector. The plasmids were named pLM136-2, pLM127-13,
and pLM135-6 and carried the bceD, bceF, and bceE genes, respectively;
they were confirmed by DNA sequencing. The empty vector or the vector
with the inserted gene was introduced into the corresponding mutant or
parental strain by triparental conjugation.
Cell line culture. The epithelial cell line used was CFBE41o-, derived from a patient homozygous for the cystic fibrosis transmembrane conductance regulator (CFTR) ⌬F508 mutation, which leads to
defects in chloride ion and water transport across the cell membrane
(43). CFBE41o- cells were routinely maintained in fibronectin/Vitrogencoated flasks in Eagle’s modified minimum essential medium (MEM)
supplemented with 10% (vol/vol) fetal bovine serum (FBS; Lonza), 1%
(vol/vol) nonessential amino acids (Gibco), L-glutamine (2 mM; SigmaAldrich), and 1% (vol/vol) penicillin-streptomycin (Sigma-Aldrich) (44)
in a humidified atmosphere at 37°C with 5% CO2.
Host cell attachment. Prior to bacterial infection, epithelial cells were
seeded onto fibronectin-coated 24-well plates (Orange Scientific) at 4 ⫻
105 cells/well in supplemented MEM without antibiotics and incubated
overnight at 37°C in a 5% CO2 atmosphere. Bacterial strains were grown
in LB until the optical density at 640 nm (OD640) reached 0.6 (log phase)
and were used to infect epithelial cells at a multiplicity of infection (MOI)
of 10 (10 bacteria to 1 epithelial cell). Bacteria were applied to the seeded
CFBE41o- cells in MEM supplemented medium, and the plates were centrifuged at 700 ⫻ g for 5 min, to facilitate bacterial attachment. The plates
were then incubated for 30 min at 37°C in an atmosphere of 5% CO2. Each
well was washed vigorously three times with phosphate-buffered saline
(PBS) to remove unbound bacteria. Cells were lysed with buffer (0.01 M
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cosmetics, and disinfectants (17). They are opportunistic pathogens, particularly for cystic fibrosis (CF) patients. Although a transient infection of the respiratory tract may occur for some patients, the acquisition of B. cepacia complex most typically results
in chronic infection (17, 18). Depending on the B. cepacia complex strain, this colonization ranges from asymptomatic to a rapid
decline of lung function characterized by a necrotizing pneumonia and the development of septicemia known as cepacia syndrome (19). Burkholderia cenocepacia and Burkholderia multivorans are the predominant species in infected CF patients (20, 21),
but an increasing number of outbreaks caused by B. cepacia complex species such as Burkholderia contaminans has been reported
(22–24). B. cepacia complex species are also intrinsically resistant
to several antibiotics and able to form biofilms, making their eradication from both lungs and clinical devices very difficult (25–27).
In vitro studies have shown that during infection of lung epithelial
cells, B. cepacia complex isolates adhere to the apical surface of the
epithelium, forming microcolonies followed by cell invasion and
disruption of tight junction integrity, promoting bacterial translocation to the basolateral surface via paracytosis (28–30). The
ability of B. cepacia complex strains to cross the epithelium paracellularly or transcellularly, penetrating the airway barriers, is associated with the ability of these bacteria to cause cepacia syndrome (31, 32).
Many B. cepacia complex virulence factors have been characterized and implicated in virulence or persistence of the infection
(reviewed in reference 33). Among these virulence factors is the
exopolysaccharide (EPS) cepacian, which has been found to be
produced by clinical and environmental Burkholderia species, including B. cepacia complex and non-B. cepacia complex species
(reviewed in reference 34). Among the proteins required for cepacian biosynthesis, the BY-kinase BceF and the LMW-PTP BceD,
which are conserved among the Burkholderia genus, seem to have
a central role in the regulation of cepacian production (35, 36). In
addition, the CF clinical isolate Burkholderia contaminans (formerly B. cepacia) strain IST408 bceF mutant showed lower swarming and swimming motilities, failed to produce biofilms on abiotic
surfaces, was less resistant to stress conditions such us UV irradiation and heat shock stress, showed attenuation of virulence in
Galleria mellonella, and was completely avirulent in a chronic
granulomatous disease gp91phox⫺/⫺ mouse infection model (7,
35, 37). As posttranslational modifications mediated by BceF and
possibly BceD proteins are implicated in several cellular processes,
including virulence properties, we investigated the importance of
both proteins in the interaction of B. cepacia complex bacteria
with host cells. Namely, we used a cystic fibrosis CFBE41o- lung
epithelial cell line model to test adhesion, invasion, tight junction
disruption, and immune stimulation by the CF clinical isolate B.
contaminans IST408 and its isogenic derivative bceD and bceF mutants.
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of the epithelial monolayers was confirmed by measuring the transepithelial electrical resistance with an epithelial volt-ohmmeter (EVOM; World
Precision Instruments). The monolayers were infected (MOI, 10) by resuspending bacteria (log phase) in antibiotic-free supplemented MEM,
which was applied onto the apical surface. The TER was measured at
different time points for up to 6 h. E. coli infection and a well containing
MEM only were used as controls of junction integrity during the assays
and to correct the resistance values obtained.
Epithelial permeability. The permeability of cell polarized monolayers was quantified by measuring the flux of fluorescein isothiocyanate
(FITC)-labeled BSA across the epithelial layer, as described previously
(30). Log-phase bacteria (MOI, 10) suspended in antibiotic-free supplemented MEM containing 0.1% (wt/vol) FITC-labeled BSA (Sigma-Aldrich) were inoculated onto the apical surface of the cell monolayer. The
medium in the basolateral chamber was initially free of FITC-labeled BSA.
At 4 and 6 h after infection, 50 l of medium was collected from the
basolateral chamber and fluorescence was measured with a multimode
microplate reader (FilterMax F5; Molecular Devices). The coefficient of
permeability (Papp) was calculated as described previously (49).
Western blot analyses. To confirm that the strains under study had
different abilities to disrupt tight junctions, polarized epithelial cell extracts from cell layers incubated with B. contaminans, E. coli (MOI, 10), or
medium alone were prepared and ZO-1, occludin, and claudin-1 levels
were analyzed by Western blotting, with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) used as loading control protein. Briefly, polarized
CFBE41o- cells were lysed 4 h postinfection by adding RIPA buffer (Sigma-Aldrich) and a protease inhibitor cocktail (Thermo Scientific) to the
filters, followed by scraping to recover cell lysate. The protein content of
the lysates was quantified by using a Nanodrop spectrophotometer, and
proteins were applied to 6% SDS-PAGE gels (for ZO-1 and occludin) or
12% gels for claudin-1. Proteins were subsequently transferred to a nitrocellulose membrane by using a Trans-Blot Turbo transfer system (BioRad) with the standard program Mix MW (25 V, 1.3 A, 7 min). Membranes were blocked with Tris-buffered saline solution containing 5%
(wt/vol) skim milk and 0.5% (vol/vol) Tween 20 (TBS-T) for 1 h. Blots
were incubated overnight at 4°C with primary antibodies against ZO-1 or
claudin-1 (Invitrogen), occludin (BD Biosciences), or GAPDH (Santa
Cruz Biotechnology), using a dilution of 1:1,000 for anti-occludin and
1:300 for the remaining antibodies. Membranes were washed three times
with TBS-T and incubated with 1:2,000-diluted goat anti-mouse serum
(Thermo Scientific) for ZO-1, occludin, and GAPDH detection and with
goat anti-rabbit serum (Santa Cruz Biotechnology) for claudin-1 detection. The secondary antibodies were conjugated to horseradish peroxidase. Following 1 h of incubation at room temperature, membranes were
washed 5 times with TBS-T. Proteins were detected by the use of ECL
reagent (Amersham Biosciences), and chemiluminescence was captured
by using a charge-coupled-device camera (Fusion Solo; Vilber Lourmat).
The density of each individual band was normalized against GAPDH by
densitometry using ImageJ software. The results are expressed as the percentage of ZO-1, occludin, or claudin-1 under each condition, compared
with the control (uninfected cells).
Proinflammatory responses of CFBE41o- cells after exposure to B.
contaminans. CFBE41o- cells were seeded into 24-well plates and incubated
under standard conditions for 24 h in supplemented MEM with heat-inactivated FBS. Cells were washed with PBS and incubated with bacteria (MOI,
10). After 24 h, supernatants were collected and centrifuged at 6,000 ⫻ g for 15
min. The samples obtained were analyzed using enzyme-linked immunosorbent assay (ELISA) MAX Deluxe kits (BioLegend), following the manufacturer’s instructions.
Lipopolysaccharide analysis. Lipopolysaccharide (LPS) was obtained
from bacteria by microextraction using proteinase K digestion of proteins
as described previously (50). Briefly, 1.5-ml aliquots of bacterial cultures
with an OD640 of 0.7 were harvested and washed with PBS. The pellet was
solubilized in 50 l of lysis buffer (2% [wt/vol] SDS, 4% [vol/vol] 2-mercaptoethanol, 10% [vol/vol] glycerol, 1 M Tris-Cl [pH 6.8], and 0.1%
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PBS, 20 mM EDTA, 0.5% Triton X-100; pH 7.4) for 30 min at 4°C. Adhesion of bacteria was quantified by CFU counts after plating serial dilutions onto LB agar and incubation for 24 h at 37°C. E. coli NCIB9415 was
used as a negative control. Duplicates of each strain were performed per
assay, and the results presented were obtained from three independent
experiments. Results are expressed as the percentage of adhesion, which
was calculated as the CFU recovered divided by the CFU applied to the
epithelial cells, multiplied by 100.
Confocal laser scanning microscopy assays. To visualize attachment
to epithelial cells, bacteria were stained by using plasmid pIN29, which
encodes the red fluorescent protein DsRed (45). This plasmid was introduced into parental strain B. contaminans IST408 or the bceD::Tp, bceE::
Tp, and bceF::Tp mutants by electroporation. Bacterial adhesion (MOI,
50) was performed as described above, but glass coverslips were placed
into 24-well plates before cell seeding. At the end of the adhesion experiment, coverslips with cells were washed with PBS. Immunostaining experiments were performed as previously described (46). For these experiments, samples were fixed with 3.7% (vol/vol) formaldehyde for 20 min,
quenched with 50 mM NH4Cl for 10 min, immersed in 0.2% (vol/vol)
Triton X-100 for 5 min, and saturated with 5% (wt/vol) bovine serum
albumin (BSA) during 30 min. Samples were then incubated with primary
mouse E-cadherin antibody (1:100; Santa Cruz Biotechnology) for 1 h 30
min, followed by washing with PBS. The secondary antibody was a polyclonal goat anti-mouse antibody coupled to Alexa Fluor 488 (1:500; Santa
Cruz Biotechnology).
Samples were examined on a Leica TCS SP5 inverted microscope
(model DMI6000; Leica Microsystems CMS GmbH, Mannheim, Germany) with a 63⫻, 1.2-numerical aperture water apochromatic objective
(47). Orthogonal projections were generated with ImageJ software (http:
//rsb.info.nih.gov/ij/).
Invasion of epithelial cells. Studies of invasion of epithelial cells were
performed as described previously (28). B. contaminans strains were applied to 4 ⫻ 105 CFBE41o- cells in MEM supplemented medium (MOI,
10). The plates were centrifuged at 700 ⫻ g for 5 min to facilitate bacterial
attachment and incubated under standard conditions (37°C, 5% CO2).
After 2 h, the MEM was removed and 500 l of ciprofloxacin (2 mg/ml)
was added to kill extracellular bacteria. After 2 h of incubation with antibiotic, cell monolayers were washed three times with PBS and incubated
in lysis buffer for 30 min at 4°C. The number of intracellular bacteria was
determined by CFU counts on LB agar. The product of the last PBS wash
before cell lysis was also plated onto LB agar to ensure that antibiotic
killing activity was greater than 99.99%. Invasion was expressed as a percentage and was calculated as the CFU recovered divided by the CFU
applied to the cells, multiplied by 100. Duplicates experiments for each
strain were performed per assay, and the results are the mean values from
three independent experiments.
Growth rates and ciprofloxacin MIC determinations. Growth rates
of the strains under study were determined in LB and MEM statically at
37°C in a 5% CO2 humidified atmosphere, and growth was measured by
monitoring the OD640 for 24 h. Growth rates were calculated from the
exponential phase of growth from at least three independent experiments.
To determine ciprofloxacin MICs, serial dilutions of Mueller-Hinton medium with ciprofloxacin ranging from 0 to 256 g/ml were inoculated
with the parental and mutant strains for 24 h at 37°C under a 5% CO2
atmosphere, and growth was determined by measuring the OD640.
Bacterial infection of polarized lung epithelial cells. The disruption
of tight junction integrity by B. contaminans strains was evaluated based
on changes in transepithelial electrical resistance (TER) in polarized
CFBE41o- cells. To obtain polarized epithelia, the cells were seeded at a
density of 6 ⫻ 105 cells/well onto Transwell permeable supports (12-mm
well; pore size, 0.4 m; Costar, Corning, NY), which were precoated with
Vitrogen (Nutacon, Netherlands). The FBS was replaced by UltraserG 24
h after seeding (48). Cells were incubated for another 24 h before removal
of the medium in the apical chamber, grown for 6 days with an air-liquid
interface, and fed basolaterally on alternate days. The functional integrity
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[wt/vol] bromophenol blue). Bacterial proteins were then digested by 1-h
incubation at 60°C with 10 l of proteinase K (2.5 mg/ml). Ten-microliter
LPS fractions were analyzed by 15% SDS-PAGE, and the LPS pattern was
revealed by silver nitrate staining according to standard protocols (51).
Statistical analysis. All quantitative data were obtained from at least
three independent assays which included duplicates for each strain. Error
propagation was used to calculate standard errors, and one-way analysis
of variance (ANOVA) statistics were used to determine P values, with
parental B. contaminans IST408 as a reference group. Differences were
considered statistically significant if the P value was lower than 0.05.

RESULTS
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Mutant strains defective in bceD or bceF genes are affected in
adhesion and invasion of lung epithelial CFBE41o- cells. B. contaminans IST408 and the phosphotyrosine phosphatase bceD::Tp
mutant produce the exopolysaccharide cepacian, although the
mutant produces 25% less EPS and it possibly has a lower molecular mass (35). In contrast, the tyrosine kinase bceF::Tp mutant is
unable to produce exopolysaccharide. To exclude that the possible
differences between the tyrosine kinase bceF::Tp mutant and the
parental strain are due to EPS production and not to the presence/
absence of the BceF kinase, the EPS-defective bceE::Tp mutant (7)
was also included in this study. The gene bceE encodes an outer
membrane protein homologous to Wza of E. coli, which is known
to oligomerize and create a channel through which the polysaccharide is exported (34).
To test differences in adhesion, the CFBE41o- cells were challenged with the bacterial strains under study at an MOI of 10.
Adherent bacteria were quantified by CFU counts after eukaryotic
cell lysis and plating onto LB agar. The results showed that the
percentage of adherent bacteria was higher in the parental B. contaminans IST408 and EPS-defective bceE::Tp mutant strains than
in the phosphotyrosine phosphatase-defective bceD::Tp or tyrosine kinase bceF::Tp mutant strains (P ⬍ 0.001 in both cases),
which had a percentage of adhesion slightly above that of the E. coli
strain used as a negative control (Fig. 1A). Complementation experiments of the bceD::Tp and bceF::Tp mutants that entailed expression of the bceD and bceF genes, respectively, from the bce
promoter present in a modified pBBR1MCS vector rescued the
mutant adhesion phenotypes to levels similar to the parental
strain, B. contaminans IST408 (Fig. 1A).
Fluorescence confocal microscopy experiments were also performed to assess bacterial adhesion after 30 min of incubation.
From the data shown in Fig. 1A, the average number of bceD::Tp
or bceF::Tp mutant cells per CFBE41o- cell was 0.25. To ensure
that these mutant cells were easily detected, the MOI was increased to 50. Ten independent fields were examined per sample,
and an image of each strain (Fig. 1B) confirmed the general low
adhesion levels shown in Fig. 1A. The confocal images of the
monolayers infected with B. contaminans IST408 and the bceE::Tp
mutant allowed visualization of bacteria attached to the cell surface. In contrast, the bceD::Tp and bceF::Tp mutants were scarcely
visible (Fig. 1B). To show that bacteria were mostly outside epithelial cells, orthogonal projections of B. contaminans IST408
and the bceD::Tp mutant were produced (Fig. 1B). To evaluate
whether the differences in bacterial adhesion had an effect on intracellular invasion, epithelial cells and each bacterial strain were
allowed to interact for 2 h, followed by treatment with ciprofloxacin to eliminate extracellular bacteria. The results obtained indicated that in comparison to the parental strain IST408, the
bceE::Tp mutant showed similar invasion levels, while the tyrosine

kinase bceF::Tp and the phosphatase bceD::Tp mutants were about
8 times less invasive (P ⬍ 0.003) (Fig. 1C). Complementation of
mutants restored intracellular invasion to levels similar to the
parental strain. The average number of invading bacteria per
CFBE41o- cell was 0.020 (⫾0.005 [standard error]) and 0.022
(⫾0.005) for the parental strain and the bceE::Tp mutant, respectively, and 0.003 (⫾0.001) for the bceD::Tp and bceF::Tp mutants.
These values are within the range obtained for other B. cepacia
complex strains (28). To exclude that the difference in invasion
was due to unequal growth rates or susceptibility to ciprofloxacin,
additional experiments were performed. As shown in Fig. 1D, no
significant differences in the growth rate, either in LB or MEM
(37°C, 5% CO2), were observed between the parental isolate and
the bceD::Tp, bceE::Tp, and bceF::Tp mutants. The MIC for ciprofloxacin, measured in Mueller-Hinton medium at 37°C and 5%
CO2, was 1 g/ml for all the strains, showing that all had the same
susceptibility to this antibiotic.
BceD and BceF proteins are required for tight junction disruption. To assess the integrity of infected polarized cell monolayers, we measured transepithelial electrical resistance and the
transepithelial flux of FITC-labeled BSA. For the first approach,
the polarized epithelial cells with a TER higher than 200 ⍀ were
challenged with each B. contaminans strain or E. coli at an MOI of
10, and changes in the TER were measured over time. After 4 h of
infection, a significant reduction of TER was observed in the epithelial cells infected with B. contaminans IST408 or the bceE::Tp
mutant (Fig. 2A). In contrast, monolayers challenged with either
the phosphotyrosine phosphatase bceD::Tp or the tyrosine kinase
bceF::Tp mutants showed a lower impact on tight junction integrity than did the parental strain (Fig. 2A). In trans complementation of bceD::Tp and bceF::Tp mutants restored TER to levels close
to that of the parental strain. Even though all B. contaminans
strains tested seemed to interfere with tight junction integrity, the
phosphotyrosine phosphatase bceD::Tp and the tyrosine kinase
bceF::Tp mutants clearly showed a phenotype attenuation over 6 h
relative to B. contaminans IST408 results (P ⬍ 0.001) (Fig. 2A).
To further demonstrate attenuation by the bceD::Tp and
bceF::Tp mutants of the compromise of the epithelial barrier, we
measured the diffusion of FITC-labeled BSA from the apical to
basolateral compartments. By 6 h postinfection, significantly
more FITC-labeled BSA was detected in the basolateral medium
of B. contaminans IST408, bceE::Tp, and complemented mutants
than was observed with the bceD::Tp or bceF::Tp mutant, E. coli, or
uninfected control polarized monolayers. These differences were
clearly visible based on the Papp calculated 4 h postinfection (Fig.
2B). The transepithelial flux of FITC-labeled BSA in the presence
of bceD::Tp and bceF::Tp mutants was comparable to that for E.
coli-infected cell monolayers or uninfected cell monolayers (below 1 ⫻ 10⫺7 cm/s). In contrast, the FITC-labeled BSA flux across
cell monolayers infected with parental IST408, bceE::Tp, or complemented mutants was in the range of 2 ⫻ 10⫺7 to 3 ⫻ 10⫺7 cm/s
(Fig. 2B).
Effect of the B. contaminans bceD or bceF mutants on tight
junction protein levels. It has been shown that a dramatic drop in
the TER indicates opening of the tight junction complexes and,
consequently, the disruption of epithelial integrity (28, 30, 52). To
confirm the disruption of these tight junction complexes by B.
contaminans, immunodetection of zonula occludens (ZO-1), occludin, and claudin-1 proteins, which play a key role in organization and regulation of tight junctions, was performed (Fig. 3A and
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C). The relative levels of ZO-1, occludin, or claudin-1 were determined by densitometry using ImageJ analysis and normalized
against the intensities obtained with the anti-GAPDH antibody.
The percentage of proteins detected was calculated against uninfected epithelia, which was considered 100%. The results presented in Fig. 3B show that the ZO-1 protein level was very low in
cells infected with the parental B. contaminans IST408 (32.3% ⫾
13.9%) and EPS-defective bceE::Tp mutant (18.3% ⫾ 4.8%), but
the epithelial monolayers infected with the BY-kinase or phosphotyrosine phosphatase mutants still had significant amounts of
ZO-1, with the bceF::Tp mutant having 59.7% ⫾ 14.0% and the
bceD::Tp 66.9% ⫾ 2.0% of the protein remaining. Mutant complementation decreased significantly the amount of ZO-1 to levels
similar to those with the parental strain and the bceE::Tp mutant.
No significant changes were observed when polarized cells were
infected with E. coli (98.2% ⫾ 12.1%). Western blot analyses for
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claudin-1 and occludin showed reductions to about 40% of their
levels in the polarized monolayers infected with the parental B.
contaminans IST408 or bceE::Tp mutant (Fig. 3C and D), while the
levels of both proteins in monolayers infected with the bceD::Tp or
bceF::Tp mutants remained slightly lower than in the uninfected
control monolayers. The immunoblots for occludin detection
showed two bands. According to Kim and collaborators (30), the
highest band should be the hyperphosphorylated form, with the
lowest representing a reduced phosphorylation level. Despite
the total reduced levels of occludin in monolayers infected with
parental IST408 or the bceE::Tp mutant, we did not see any differences in the relative levels of each of the two bands compared to
the uninfected polarized cells.
Mutant strains defective in bceD and bceF genes inhibit IL-8
and IL-6 release. Proinflammatory cytokines have been shown to
be increased in lungs of children with CF (53) and are associated
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FIG 1 Cellular adhesion and invasion. (A) Adhesion of B. contaminans IST408 parental strain harboring pBBR1MCS and of mutants (bceD::Tp/pBBR1MCS,
bceE::Tp/pBBR1MCS, and bceF::Tp/pBBR1MCS), complemented mutants (bceD::Tp/pbceD, bceE::Tp/pbceE, bceF::Tp/pbceF), and E. coli NCIB9415 to
CFBE41o- lung epithelial cells, using an MOI of 10. Data are the mean of three independent experiments. A difference for which the P value was ⬍0.001
(indicated with an asterisk) was considered statistically significant compared to B. contaminans IST408/pBBR1MCS. pBBR, pBBR1MCS. (B) Fluorescence
confocal microscopy images of CFBE41o- lung epithelial cells infected with B. contaminans strains (MOI, 50). Orthogonal projections of the confocal stack are
also shown for the parental B. contaminans IST408 and bceD::Tp mutant. Eukaryotic cell plasma membrane was stained with an antibody to E-cadherin by using
Alexa Fluor 488 (green). Bacteria were labeled with DsRed. (C) Invasion of CFBE41o- epithelial cells by B. contaminans IST408/pBBR1MCS, mutants bceD::Tp/
pBBR1MCS, bceE::Tp/pBBR1MCS, and bceF::Tp/pBBR1MCS, or complemented mutants (bceD::Tp/pbceD, bceE::Tp/pbceE, or bceF::Tp/pbceF) (MOI, 10). The
results are from three independent experiments. The significance levels of the differences between the mutants and the parental strain were analyzed by one-way
ANOVA. *, P ⬍ 0.003. (D) Growth rates of B. contaminans IST408, bceD::Tp, bceE::Tp, and bceF::Tp mutants grown in LB or MEM at 37°C under an atmosphere
of 5% CO2. Growth was determined by OD640 measurements, and data are the averages of at least three independent experiments.

Roles of BceD and BceF in Bacterium-Host Interactions

difference between the LPS patterns of the parental versus the
mutant strains (Fig. 4C), excluding the possibility that the differential cytokine levels released by the epithelial cells was caused by
major structural changes or in the quantity of the LPS produced by
the bacteria.
DISCUSSION

with a poorer prognosis, as the accumulation of IL-6 and IL-8 in
lung tissue leads to an exacerbation of the immune system and
tissue damage (54). To evaluate whether the tyrosine kinase
bceF::Tp and the phosphatase bceD::Tp mutants were able to trigger the same immune response as the parental IST408 strain, we
quantified IL-6 and IL-8 production by CFBE41o- cells after 24 h
of bacterial infection. The results obtained showed that both IL-6
and IL-8 production levels were higher in epithelial cells infected
with the parental IST408 or with the bceE::Tp mutant than in the
cells infected with the mutants bceD::Tp and bceF::Tp or the control without bacteria (Fig. 4A and B). Complementation of the
bceD::Tp and bceF::Tp mutants under study rescued the production of both cytokines to levels similar to those in epithelial cells
infected with the parental strain.
As previous expression profiling of the bceF::Tp mutant
showed that several genes involved in LPS biosynthesis are differentially expressed (7), we analyzed the LPS pattern of the different
strains via SDS-PAGE. Under the tested conditions, there was no
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FIG 2 Integrity of polarized CFBE41o- monolayers upon exposure to B. contaminans strains. (A) TER was measured over time in polarized cells infected
with the parental IST408/pBBR1MCS, its derivative mutants bceD::Tp, bceE::
Tp, and bceF::Tp, or complemented mutants bceD::Tp/pbceD, bceE::Tp/pbceE,
bceF::Tp/pbceF, and E. coli NCIB9415, or in uninfected cells. Data are the
percent change (⫾ the standard error of the mean) from the initial TER at each
time point. (B) Permeability of cell monolayers (Papp) was determined by
measuring the flux of FITC-labeled BSA from apical to basolateral media. All
infections were done at an MOI of 10, and data represent the means of three
independent experiments. Asterisks indicate values that were significantly different from the ones obtained for polarized cells infected with IST408/
pBBR1MCS (P ⬍ 0.05).

Most of the research on CF B. cepacia complex pathogenicity has
been dedicated to B. cenocepacia, since this species, together with
B. multivorans, accounts for approximately 80% of B. cepacia
complex infections worldwide (20). However, several reports have
shown that other B. cepacia complex species, among them B. contaminans, are also implicated in transient or chronic infections,
poor prognosis, and transmission between patients (20, 21, 55).
To gain insights into the B. contaminans interaction with host
cells, we investigated the role of a BY-kinase and an LMW-PTP in
this process, as some of their homologues are known to interfere
with host signaling (8). Previous expression profiling and phenotype characterization of the parental strain B. contaminans IST408
and the bceD::Tp and the bceF::Tp mutants (7, 35) indicated that
BceD and BceF are involved in multiple phenotypic characteristics, including motility, biofilm formation, EPS biosynthesis, resistance to stress conditions, and virulence in the Galleria mellonella model. These observations suggest the existence of a complex
regulatory network where the tyrosine phosphorylation state of a
target protein(s), mediated by the BY-kinase BceF, possibly in
conjunction with the PTP BceD, plays a fundamental role. Although several BceF homologues have been characterized and
their roles in the regulation of protein function and cellular location demonstrated (3), little is known about their importance in
host-pathogen interactions. As an example, analysis of the E. coli
O157:H7 phosphotyrosine proteome showed that phosphorylation of a tyrosine residue of the regulator SspA positively affected
expression and secretion of T3SS proteins and formation of A/E
lesions on HeLa cell monolayers (56). Similarly, a few LMW-PTP
proteins homologous to BceD are known to interfere in several
host signaling pathways (8, 16). Accordingly, in our work we
tested the importance of BceF and BceD in the pathogenesis of B.
contaminans infection by using the CFBE41o- cell line as a model.
An important observation is that the absence of the BY-kinase or
the LMW-PTP phosphatase is associated with similar phenotypes
while interacting with CFBE41o- cells. This suggests that BceF and
BceD, by having global regulatory functions, may act on the same
unknown bacterial pathway that ultimately leads to the adhesion/
invasion and tight junction disruption phenotypes observed here.
The three-dimensional structures of BY-kinases suggest that the
phosphatase may be critical for the cycling of the kinase between
monomers and higher-order oligomers (57). In this situation, not
having BceF or having it in an inactive monomeric/oligomeric
state due to the absence of BceD would perhaps result in the same
cellular outcome regarding interactions with host cells.
The B. cepacia complex infection process starts with adhesion
of bacteria to the apical surface of epithelial cells (29), but little is
known about the structures involved in this host-bacterium interaction. Although some adhesin proteins of B. cenocepacia have
been implicated in attachment to epithelial cells (46, 58, 59), no
studies on the putative adhesins of B. contaminans IST408 have
been done. Previous expression profiling (under growth conditions dissimilar from the ones tested here) of the bceF mutant
compared to the IST408 parental strain showed decreased ex-
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occludin, claudin-1, and GAPDH levels (C) in CFBE41o- monolayers after 4 h of exposure to each of the strains under study. Densitometry analysis of ZO-1
expression (B) and occludin and claudin-1 expression (D) were determined by using ImageJ software. Numbers in the Western blot lanes (A and C) correspond
to the strain names indicated in charts B and D. Band intensities for ZO-1, claudin-1, and occludin, determined from three independent experiments, were
normalized against GAPDH and are expressed as the mean percent change ⫾ the standard deviation, relative to results in control uninfected cells. Asterisks
indicate values that were significantly different than the ones obtained for cells infected with the parental strain, B. contaminans IST408 (P ⬍ 0.05).

pression of a putative autotransporter adhesin homologue to
BCAS0321 of B. cenocepacia J2315 and at least eight genes encoding putative outer membrane porins (7). Therefore, further experiments are needed to attribute a possible role of B. contaminans
IST408 adhesin/Omp proteins to the CFBE41o- cell adhesion
phenotype. Studies also have shown that in some B. cepacia complex species, the invasion process starts with the formation of microcolonies and of biofilms reassembling structures in the mucous
layer that eventually reach the epithelial surface (29). Previous
data on bceD::Tp and bceF::Tp mutant biofilm formation showed
that they form less biofilm on abiotic surfaces than the parental
strain or the bceE::Tp mutant (7, 35). This phenotype correlates
with the adhesion/invasion ability of the B. contaminans tested
strains toward the CFBE41o- cells in this study, suggesting that the
formation of biofilm-like structures on the cell surface might be
important for B. contaminans cellular invasion.
Some species of the B. cepacia complex invade eukaryotic cells
via a membrane-bound vacuole, where bacteria have been shown
to survive by escaping from late endosomes and replicating within
epithelial cells (26, 32, 60). Besides cellular invasion, B. cepacia
complex species have been shown to transverse the respiratory
epithelium paracellularly, which may be associated with the B.
cepacia complex ability to disseminate beyond the lungs at a
higher frequency than other CF pathogens, causing cepacia syn-
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drome (31). Accordingly, B. cepacia complex migration to the
basolateral surface of epithelium is associated with a strong decrease of TER due to the loss of cell junction integrity (29). Duff
and collaborators have shown that 4 different species within the B.
cepacia complex are able to disrupt epithelial monolayer integrity
and translocate through to the basolateral side of lung epithelial
monolayers (28). In our study, B. contaminans parental strain
IST408 also dramatically reduced transepithelial resistance and
increased the permeability of polarized CFBE41o- monolayers. In
contrast, the abilities of bceD::Tp and bceF::Tp mutants to impair
tight junction integrity were closer to those of the negative controls. Bacterial pathogens can interfere with epithelial tight junction integrity by different mechanisms, including changes at the
expression level or phosphorylation level or dislocation of tight
junction proteins (61–63). In B. cepacia complex bacteria, representative isolates of three epidemic lineages of B. cenocepacia have
been shown to transverse polarized 16HBE41o- respiratory epithelial cells (non-CF) in vitro by dephosphorylation and dissociation of occludin from the tight junction complex, but no difference was observed for ZO-1 protein (30). In another study with
environmental B. cenocepacia strains, no apparent effect on the
tight junction protein ZO-1 was observed in non-CF polarized
16HBE41o- cells, while in CF polarized cells CFBE41o- cells, the
amount of ZO-1 and its localization were altered (52). In our
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FIG 3 Western blot analysis of infected polarized CFBE41o- monolayers. Total cell extracts were analyzed for estimation of ZO-1 and GAPDH levels (A) and

Roles of BceD and BceF in Bacterium-Host Interactions

(A) and IL-8 (B) were measured by ELISA, and results represent the averages of three independent assays. Asterisks indicate values that were significantly different
from the ones obtained for uninfected cells (P ⬍ 0.006). (C) SDS-PAGE of lipopolysaccharide extracted from the indicated B. contaminans strains. Protein-free
cell extracts were separated in 15% SDS-PAGE gels, and LPS was visualized by silver staining.

study, we observed a reduction of ZO-1, occludin, and claudin-1
levels and these were more pronounced in parental B. contaminans IST408 and the bceE::Tp mutant than in the bceD::Tp and
bceF::Tp mutants. The mechanism by which BceD and BceF affect
tight junction integrity is unknown. BceF is an inner membrane
protein, and its role in this disruption is most likely indirect. Regarding BceD, this protein could be secreted and interfere with
host cell functions. Nevertheless, a recent study by Andrade and
Valvano showed that under the in vitro experimental conditions
tested, BceD was not detected in the growth medium (16). Despite
this result, it cannot be excluded that, in the presence of CFBE41ocells, BceD may be secreted.
The development of cepacia syndrome is also associated with
increased levels of proinflammatory cytokines in blood and sputum (64), particularly with a large amount of IL-8 (53), which
attracts neutrophils and macrophages into the CF lung. These cells
of the immune system release free radicals and proteolytic enzymes to eliminate bacteria, but these mechanisms have been
shown to be inefficient against B. cepacia complex bacteria and
contribute to a further increase in lung damage and to the establishment of chronic inflammation (64). In this work, we have
shown that in the absence of BceD and BceF proteins, B. contaminans induces a lower proinflammatory response. Although the
LPS profiles of the wild-type and mutant strains were comparable,
it cannot be excluded that modifications of lipid A acylation or
phosphorylation levels might occur. Expression profiling analysis
of the B. contaminans bceF::Tp mutant indicated an upregulation
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of the lpxO gene, which encodes a putative dioxygenase required
for acyl chain hydroxylation (7), suggesting that different degrees
of 2-hydroxylation might be present with bceF::Tp mutant and
wild-type strains. Modified lipid A structures with different phosphorylation or acylation patterns elicit different host immune responses (65, 66). Nevertheless, Palfreyman and coauthors showed
that B. cepacia complex cell-free supernatants can also increase
IL-8 production, suggesting that other factors besides LPS can
enhance the immune response (67). The reduced inflammatory
response could also be due to the lower level of attachment to host
cells and a concomitant lack of direct stimulation of epithelial
cells. Further investigation into the adhesins and host pattern recognition receptors involved will help elucidate the mechanism.
Taken together, our results indicate that the BceF and BceD proteins have an important role in B. contaminans virulence, since a
range of critical events involved in the infection of CF lung epithelial cells was compromised in both mutants. Moreover, since
the BceF and BceD proteins have homologues in both Gram-negative and Gram-positive bacteria, their involvement in virulence
might be a common feature among pathogens.
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FIG 4 Bacterial strain LPS profiles and secretion of cytokines by CFBE41o- epithelial cells following exposure to B. contaminans. (A and B) Cytokine levels of IL-6
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